These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Preliminary study of the efficacy and tolerability of combination therapy with calcipotriene ointment 0.005% and tacrolimus ointment 0.1% in the treatment of stable plaque psoriasis. Tirado-Sánchez A, Ponce-Olivera RM. Cutis; 2012 Sep; 90(3):140-4. PubMed ID: 23094314 [Abstract] [Full Text] [Related]
8. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis. Singalavanija S, Noppakun N, Limpongsanuruk W, Wisuthsarewong W, Aunhachoke K, Chunharas A, Wananukul S, Akaraphanth R. J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874 [Abstract] [Full Text] [Related]
10. Efficacy and tolerability of topical tacrolimus ointment for the treatment of male genital psoriasis. Bissonnette R, Nigen S, Bolduc C. J Cutan Med Surg; 2008 Nov; 12(5):230-4. PubMed ID: 18845092 [Abstract] [Full Text] [Related]
13. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study. Schachner LA, Lamerson C, Sheehan MP, Boguniewicz M, Mosser J, Raimer S, Shull T, Jaracz E, US Tacrolimus Ointment Study Group. Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675 [Abstract] [Full Text] [Related]
18. 0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study. Ortonne JP, van de Kerkhof PC, Prinz JC, Bieber T, Lahfa M, Rubins A, Wozel G, Lorette G, European Tacrolimus Psoriasis Study Group. Acta Derm Venereol; 2006 Sep; 86(1):29-33. PubMed ID: 16585986 [Abstract] [Full Text] [Related]